Revolution Medicines

accelerated
Biotech

Regeneron, Sanofi receive 1- to 2-month priority review vouchers

The national priority vouchers position companies including Merck KGaA, Regeneron and Sanofi to complete the review process in one to two months.
Nick Paul Taylor Oct 17, 2025 8:30am
Parachute over a mountain in Switzerland

GSK chief steps down in stunning move—Chutes & Ladders

Oct 3, 2025 8:30am
Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Revolution taps Iambic's AI models in $25M discovery deal

Jul 9, 2025 11:19am
increase

Royalty signs off $2B to bankroll Revolution's RAS cancer drug

Jun 24, 2025 9:00am
An artists illustration of a KRAS G12C mutation in non-small cell lung cancer

AACR: KRAS inhibitors pop in preclinical data debuts

Apr 11, 2024 4:30am
unravel break rope tie fray fall apart thread string

The unraveling of EQRx's low-cost drug dream

Oct 5, 2023 10:47am